9 results on '"Viatris Inc. -- Forecasts and trends"'
Search Results
2. Bronchial Spasm Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight
3. Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale
4. Post-Surgical Pain Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, and Forecast by DelveInsight | Novartis, MedinCell, Unither, Esteve, Formosa, Acadia, Teikoku
5. Global Motion Sickness Drugs Market 2022 to 2026: Featuring Aurobindo Pharma, Baxter International, Caleb Pharmaceuticals, Cipla and CVS Health Among Others
6. $4.2 Billion Overactive Bladder Treatment (OAB) Markets - Global Forecasts to 2027: Growing R&D Investments and the Launch of Novel Therapies in the Coming Years
7. Antiparasitic Drugs Global Market Report 2022: Government, Non-Profit and Market Player Initiatives to Boost Adoption Bode Well For Growth
8. The Worldwide Non-steroidal Anti-inflammatory Drugs Industry is Expected to Reach $25.5 Billion by 2028
9. Global Alzheimer's Therapeutics Market Report (2022 to 2032) - Players Include Macleods Pharmaceuticals, Viatris, Lupin and Cipla
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.